Early research (Phase 1)Ended earlyNCT05069935What this trial is testingFT538 in Combination With Monoclonal Antibodies in Advanced Solid TumorsWho this might be right forSolid Tumor, Adult Fate Therapeutics 16
Testing effectiveness (Phase 2)Ended earlyNCT00258297What this trial is testingGefitinib in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer That Can Be Removed By SurgeryWho this might be right forEsophageal Cancer University of Rochester 30
Early research (Phase 1)Looking for participantsNCT03740256What this trial is testingBinary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid TumorsWho this might be right forBladder CancerHead and Neck Squamous Cell CarcinomaCancer of the Salivary Gland+7 more Baylor College of Medicine 45
Large-scale testing (Phase 3)Active Not RecruitingNCT05078047What this trial is testingStudy Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IOWho this might be right forLung Cancer MetastaticRenal Cell CarcinomaHead and Neck Cancer+12 more UNICANCER 646
Large-scale testing (Phase 3)Study completedNCT01243398What this trial is testingGefitinib in Treating Patients With Esophageal Cancer That is Progressing After ChemotherapyWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionEsophageal Cancer University of Oxford 450
Testing effectiveness (Phase 2)Study completedNCT00397904What this trial is testingCetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and CisplatinWho this might be right forEsophageal CancerGastric Cancer Memorial Sloan Kettering Cancer Center 16
Not applicableEnded earlyNCT01868139What this trial is testingSpray Cryotherapy for Esophageal Cancer (ICE-CANCER)Who this might be right forEsophageal Cancer University of Maryland, Baltimore 1
Early research (Phase 1)Ended earlyNCT00732745What this trial is testingVandetanib, Oxaliplatin, and Docetaxel in Advanced Cancer of the Esophagus or Gastroesophageal JunctionWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionEsophageal Cancer Case Comprehensive Cancer Center 9
Testing effectiveness (Phase 2)Study completedNCT00069953What this trial is testingCombination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionWho this might be right forEsophageal Cancer Radiation Therapy Oncology Group 43
Testing effectiveness (Phase 2)Study completedNCT02971956What this trial is testingPembrolizumab in Refractory Advanced Esophageal CancerWho this might be right forEsophageal CancerSquamous Cell Esophagus CancerAdenocarcinoma Esophagus Dana-Farber Cancer Institute 49
Testing effectiveness (Phase 2)Ended earlyNCT00268437What this trial is testingRadiation Therapy, Pemetrexed Disodium, and Carboplatin in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By SurgeryWho this might be right forEsophageal Cancer Alliance for Clinical Trials in Oncology 27
Early research (Phase 1)Study completedNCT02635672What this trial is testingPhase I Dose Escalation Study for VIP152 in Patients With Advanced CancerWho this might be right forNeoplasms Vincerx Pharma, Inc. 110
Not applicableStudy completedNCT02890979What this trial is testingSwallowable Sponge Cell Sampling Device and Next Generation Sequencing in Detecting Esophageal Cancer in Patients With Low or High Grade Dysplasia, Barrett Esophagus, or Gastroesophageal Reflux DiseaseWho this might be right forBarrett EsophagusDysplasiaEsophageal Adenocarcinoma+3 more OHSU Knight Cancer Institute 11
Not applicableLooking for participantsNCT04510129What this trial is testingCancer Biospecimen Collection StudyWho this might be right forCancer of Head and NeckLung Cancer, Nonsmall CellSmall-cell Lung Cancer+8 more Cofactor Genomics, Inc. 1,650
Not applicableStudy completedNCT00900094What this trial is testingUMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With CancerWho this might be right forBreast CancerColorectal CancerEsophageal Cancer+4 more University of Michigan Rogel Cancer Center 200
Testing effectiveness (Phase 2)Study completedNCT01612546What this trial is testingPilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by SurgeryWho this might be right forAdenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the Stomach+11 more City of Hope Medical Center 10
Early research (Phase 1)Study completedNCT00397384What this trial is testingErlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerWho this might be right forAdenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more National Cancer Institute (NCI) 43
Early research (Phase 1)Study completedNCT00030498What this trial is testingErlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more National Cancer Institute (NCI) 75
Testing effectiveness (Phase 2)Looking for participantsNCT05914116What this trial is testingA Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid TumorsWho this might be right forAdvanced Solid Tumors DualityBio Inc. 862
Early research (Phase 1)Study completedNCT04641871What this trial is testingSym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor MalignanciesWho this might be right forMetastatic CancerSolid Tumor Symphogen A/S 78